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Aluminum posttranscriptional regulation of parathyroid hor-
mone synthesis: A role for the calcium-sensing receptor.
Background. Calcium regulates parathyroid hormone (PTH)
gene expression by a posttranscriptional mechanism, as well as
parathyroid gland growth through the activation of the calcium-
sensing receptor. Aluminum decreases both parathyroid cell
proliferation and PTH levels by an unknown mechanism.
Methods. To investigate the possible role of calcium-sensing
receptor in the aluminum-induced PTH inhibition we used hu-
man embryonic kidney (HEK-293) cells transiently transfected
with the human calcium-sensing receptor. We used a parathy-
roid gland tissue culture model to investigate whether the effect
of aluminum in PTH mRNA was a transcriptional mechanism
and also its possible role in calcium-sensing receptor expression.
Results. We found that Al activated the calcium-sensing re-
ceptor with higher efficiency than calcium, its biologic ligand.
Aluminum inhibited PTH gene expression by a posttranscrip-
tional mechanism, but only when low calcium is present in the
medium. Finally, we found that aluminum is also able to de-
crease calcium-sensing receptor mRNA levels by a posttran-
scriptional mechanism; however, no effect was observed on
calcium-sensing receptor protein.
Conclusion. These findings indicate that aluminum impairs
parathyroid function through a calcium-like mechanism due to
the lack of specificity of the calcium-sensing receptor. Addition-
ally, aluminum decreases parathyroid calcium-sensing receptor
mRNA levels, and the regulatory mechanism was posttranscrip-
tional. These findings demonstrate for the first time a regulatory
effect in the calcium-sensing receptor by one of its ligands.
Aluminum-related bone disease has been a major
problem for a significant group of chronic kidney dis-
ease (CKD) patients [1–3]. Besides its direct effects on
bone [4, 5], aluminum can also impair calcium home-
ostasis by decreasing parathyroid hormone (PTH) lev-
els [6]. Initially, aluminum-induced PTH inhibition was
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only thought to affect hormone secretion [7, 8]. How-
ever, using rats with CKD, we have described a dose-
dependent effect of aluminum on both PTH secretion
and synthesis [9]. Moreover, in CKD rats in vivo we have
also found an inhibitory effect of aluminum on parathy-
roid cell proliferation [10]. These findings were similar to
those previously described for calcium [11, 12], suggest-
ing that both cations may share some common regulatory
pathways in the parathyroid gland. Extracellular calcium
([Ca+2]E) is sensed by the calcium-sensing receptor and
regulates PTH gene expression by a posttranscriptional
mechanism which does not affect gene transcription, but
does affect PTH mRNA stability [13]. In contrast, lim-
ited data are available on the exact mechanism by which
aluminum is sensed by the parathyroid cells and results
in PTH reduction. The calcium-sensing receptor cloned
in the parathyroid glands and in other tissues [14–16] has
been shown to be a promiscuous receptor [17] that re-
sponds to a wide variety of cations [14, 18]. Aluminum
has also been reported to activate calcium-sensing recep-
tor, but only at a milimolar concentration [19], which is
considerably higher than the levels reported to suppress
PTH [9, 10].
Our hypothesis was that aluminum was able to regu-
late parathyroid function through a calcium-like mech-
anism due to the lack of specificity in the calcium-
sensing receptor. Therefore, we used different aluminum
carriers and human embryonic kidney (HEK-293) cells
transfected with the human calcium-sensing receptor to
determine whether aluminum by itself was able to acti-
vate the receptor within the physiologic range. We also
developed a parathyroid gland tissue culture model to
study whether aluminum and calcium share the same
regulatory mechanisms. Effects on PTH synthesis were
analyzed by Northern-blot, quantitative real-time poly-
merase chain reaction (PCR) and nuclear run-on assays.
Effects on parathyroid cell proliferation were analyzed
by immunohistochemistry, using a monoclonal antibody
to the proliferating cell nuclear antigen (PCNA). Fi-
nally, we evaluated the possible role of aluminum on
calcium-sensing receptor gene expression by quantitative
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real-time PCR and run-on assays and on calcium-sensing
receptor protein by immunohistochemistry, using a poly-
clonal antibody to the rat calcium-sensing receptor.
METHODS
Aluminum carriers and aluminum quantification
We assayed four different aluminum carriers [alu-
minum citrate, aluminum transferrin, aluminum-
overloaded rat serum (aluminum serum), and AlCl3] in
order to increase the bioavailability of the metal. Both
citrate and transferrin had been reported as suitable
aluminum carriers [20, 21]. We chose aluminum serum
as an attempt to reproduce the physiologic environment.
Aluminum citrate. Equimolecular volumes of AlCl3.6
H2O and dehydrated sodium citrate were mixed in
5 mmol/L Tris-HCl, pH 7.4, to prepare a 1 mmol/L
aluminum citrate solution. Final concentration in the
medium was 100 lmol/L. Sodium citrate at the same pH
and concentration was used as control.
Aluminum transferrin. Human apotransferrin (Sigma
Chemical Co., St. Louis, MO, USA) was used to prepare
1 mmol/L aluminum transferrin solutions following the
method described by Trapp [20]. Final aluminum trans-
ferrin concentration in the medium was 100 lmol/L. Hu-
man apotransferrin of the same pH and concentration
was used as control.
Aluminum serum. Preparation of aluminum serum
was similar to that used for aluminum transferrin.
Equimolecular volumes of AlCl3.6 H2O and nitriloac-
etate (NTA) were mixed in 5 mmol/L Tris-HCl, pH 7.4,
to prepare a 0.1 mol/L aluminum-NTA solution. Addi-
tionally, a serum pool was generated with blood from
4-month-old normal Wistar rats. Serum was then sepa-
rated into 10 mL aliquots and incubated with 100 lL/
1 mol/L NaHCO3 and 120 lL/0.1 mol/L aluminum-NTA
for 2 hours at room temperature and then overnight at
4◦C. Aliquots were dialyzed twice against 40 volumes of
5 mmol/L Tris-HCl, pH 7.4, for 8 hours.
Total aluminum in serum was quantified by graphite
furnace atomic absorption spectrometry (Perkin-Elmer,
Uberlingen, Germany) as previously described [22]
and found to be approximately 1 mmol/L. Final
aluminum serum concentration in the medium was
100 lmol/L. Dialyzed aluminum-free rat serum was used
as control.
In vitro calcium-sensing receptor activation study
HEK-293 cells (CLR-1573, ATCC-LGC) (Promo-
chem, Teddington, UK) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Life Technologies,
Grand Island, NY, USA) with 10% fetal calf serum (FCS),
100 U/mL penicillin, and 100 lg/mL streptomycin sulfate
(all from Biochrom AG, Berlin, Germany) at 37◦C in a
humidified atmosphere with 5% CO2. Cells were tran-
siently transfected with a pcDNA3.1 expression vector
(Invitrogen, Carlsbad, CA, USA) containing the human
calcium-sensing receptor gene [23] by using the calcium-
phosphate method [24]. Calcium-sensing receptor ac-
tivation was assessed after 48 hours. Transfected cells
were then washed and resuspended in a calcium-free,
aluminum-free Hank’s balanced salt solution (HBBS)
buffer without antibiotics (HBBS 118 mmol/L NaCl,
4.6 mmol/L KCl, 10 mmol/L D-glucose, and 20 mmol/L
Hepes, pH 7.3). Cells were loaded for 1 hour at room
temperature with fura-2/AM (Molecular Probes Inc., Eu-
gene, OR, USA) in HBBS buffer, washed again in HBBS
buffer, and finally placed in an ultraviolet-grade cuvette.
Fluorescence emission was measured after the addition
of increasing amounts of either CaCl2 or aluminum car-
riers: aluminum citrate, aluminum transferrin, and alu-
minum serum (Kontron Instruments, Munich, Germany).
Sodium chloride, sodium citrate, human apotransferrin
or dialyzed aluminum-free rat serum were, respectively,
used as negative controls. We also assayed an inorganic
aluminum compound, AlCl3.
Excitation wavelengths for fura-2/calcium and fura-2
alone were 340 and 380 nm, respectively, and fluores-
cence emission was detected at 510 nm. The 340/380 flu-
orescence ratio of emitted light was used to calculate the
intracellular calcium concentration ([Ca+2]i) as an indi-
cator of calcium-sensing receptor activation [17]. In all
AlCl3 experiments, supernatants were collected and ul-
tracentrifuged at 20,000 × g for 30 minutes. Then, alu-
minum in solution was measured by graphite furnace
atomic-absorption spectrometry as previously described
[22].
Parathyroid tissue culture
Parathyroid glands were obtained from 4-month-old
male Wistar rats (N = 424), with normal renal function,
after being anesthetized by CO2 and exanguinated by aor-
tic puncture. The parathyroid glands were excised from
the thyroid tissue under a stereomicroscope (Olympus
Model SZ-ST) (Tokyo, Japan) and placed into a nylon
basket containing a permeable membrane of 12 lm pore
size, physically isolating the glands from the bottom of the
well (Transwell Costar, Corning, NY, USA). Each exper-
iment was performed by pooling 20 parathyroid glands
(10 glands in each group). The glands were constantly
shaken (AOS-0 SBS Instruments SA, Badalona, Spain)
at 37◦C with 2 mL of a medium containing 125 mmol/L
NaCl, 5.9 mmol/L KCl, 1.2 mmol/L MgCl2, 1 mmol/L
sodium pyruvate, 4 mmol/L L-glutamine, 12 mmol/L D-
glucose, 25 mmol/L sodium Hepes, 0.1 U/mL insulin,
0.1% bovine serum albumin (BSA), 100 U/mL penicillin,
and 100 lg/mL streptomycin sulfate buffered at pH 7.4
[25]. Phosphorus was added as NaH2PO4 and Na2HPO4
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in 1:2 proportions to achieve a final phosphorus concen-
tration of 1 mmol/L. CaCl2 was used at two different
concentrations, 0.60 or 1.40 mmol/L (Sigma-Aldrich, St.
Louis, MO, USA). After 8 hours of washing, changing
the medium every 2 hours, the glands were incubated for
24 hours with different aluminum carriers: aluminum cit-
rate, aluminum transferrin, or aluminum serum. Media
samples were taken after 24 hours and PTH secretion
was measured by an immunoradiometric assay (IRMA)
rat PTH assay (Nichols Institute, San Juan Capistrano
CA, USA). In order to test the culture model, a group of
glands were cultured for 48 hours in the same medium,
containing either 10−8 mol/L calcitriol or vehicle. All pro-
cedures involving rats were conducted in accordance with
approved Institutional Animal Use Ethics Committee
protocols.
Northern blot
Total RNA was isolated from the parathyroid tissues
using TRITM Reagent (Sigma Chemical Co.) and fol-
lowing the manufacturer’s instructions. Approximately
5 lg RNA/well were electrophoretically separated in
1.2% agarose-formaldehyde gels, blotted onto Zeta
Probe GT nylon membranes (Bio-Rad, Hercules, CA,
USA) and then hybridized according to the manu-
facturer’s instructions. After hybridization, membranes
were exposed to an electronic autoradiography system
(Instantimager) (Packard, Meriden, CT, USA) and to
HyperfilmTM MP autoradiographic films (Amersham,
Piscataway, NJ, USA). The PTH cDNA probe was kindly
provided by Dr. Armando Torres and Dr. Eduardo Salido
(Tenerife, Spain) and the 28S cDNA probe was supplied
by Dr. Lourdes Mozo (Oviedo, Spain).
Real-time PCR
Quantitative real-time PCR was performed on an ABI
Prism 7000 Sequence Detection System (PE Applied
Biosystems, Foster City, CA, USA) using SyBr Green
PCR Master Mix for PTH gene and TaqMan Univer-
sal PCR Master Mix for calcium-sensing receptor and
18S genes (PE Applied Biosystems). The cDNA was ob-
tained from 2 lg of total RNA using TaqMan Reverse
Transcription reagents (PE Applied Biosystems) follow-
ing manufacturer’s instructions. Primer Express Software
(PE Applied Biosystems) was used to design appropri-
ate primer pairs and florescent probes. Primer pairs for
PTH gene were synthesized by Invitrogen: Sense TTG
TCT CCT TAC CCA GGC AGA T; and antisense TTT
GCC CAG GTT GTG CAT AA. Calcium-sensing recep-
tor gene and endogenous control (18S) were analyzed by
using predeveloped assays (TaqMan Gene Expression
Assays-On-Demand Rn 00566496 m1 and Eukaryotic
18s rRNA Endogenous Control reagent, respectively)
(PE Applied Biosystems). For TaqMan analysis, all re-
actions (in quadruplicate) were performed by amplify-
ing endogenous and target genes in the same plate. To
check reaction sensitivity, serial dilutions of the cDNA
(1/10, 1/200, 1/500, and 1/1000) were amplified for en-
dogenous and target genes in preliminary experiments.
Relative quantitative evaluation (User Bulletin #2) (PE
Applied Biosystems,) of target genes was performed by
comparing threshold cycles, as previously described [26].
Nuclear run-on transcription assay
Isolation of cell nuclei, run-on transcription, and hy-
bridization were performed essentially as previously de-
scribed [27]. Groups of 30 parathyroid glands were
washed using ice-cold phosphate-buffered saline (PBS),
homogenized in a dounce homogenizer with a type
“A” pestle (Afora, Barcelona, Spain) in ice-cold sucrose
buffer I [0.25 mol/L sucrose, 10 mmol/L Hepes, pH 8.0,
10 mmol/L MgCl2 0.1% Triton X-100, amd 2 mmol/L
dithiothreitol (DTT)] and nuclei were pelleted by cen-
trifugation for 5 minutes at 500 × g. Supernatant was
collected in order to isolate cytoplasmic mRNA from
the same glands as previously described [28]. mRNA
was then reverse-transcribed into cDNA and PTH and
calcium-sensing receptor mRNA levels were measured
by quantitative real-time PCR analysis.
Cell nuclei were re-suspended in sucrose buffer I and
then placed over a sucrose buffer II cushion (1 mol/L
sucrose, 10 mmol/L Hepes, pH 8, 10 mmol/L MgCl2
0.1% Triton X-100, and 2 mmol/L DTT). After centrifu-
gation (5 minutes at 500 × g, 4◦C), the nuclear pellet
was resuspended in [40% glycerol, 50 mmol/L Tris-HCl,
pH 8.3, 5 mmol/L MgCl2, and 0.1 mmol/L ethylene-
diaminetetraacetic acid (EDTA)] at a concentration of
5 × 107 nuclei/100 lL, snap-frozen, and finally stored at
−80◦C. For run-on transcription, 100 lL of frozen nu-
clei were added to 100 lL of reaction buffer [10 mmol/L
Tris-HCl, pH 8.3, 5 mmol/L MgCl2, 0.3 mmol/L KCl,
5 mmol/L DTT, 1 mmol/L each adenosine triphos-
phate (ATP), cytidine triphosphate (CTP), and guanine
triphosphate (GTP), 40 U RNase inhibitor (Roche, Basel,
Switzerland), 100 lCi [a-32P] uridine triphosphate (UTP)
800 Ci/mmol (Amersham Biosciences)] and incubated
at 30◦C for 30 minutes. The reaction was stopped with
800 lL of TRITM Reagent (Sigma-Aldrich) and then to-
tal RNA was extracted.
Linearized plasmid constructions containing cold
cDNA probes for PTH (1 lg/well), calcium-sensing re-
ceptor (1 lg/well), glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (0.2 lg/well) and pUC18 (1 lg/well)
were alkali-denatured and immobilized onto Zeta
Probe GT nylon membranes (Bio-Rad). The calcium-
sensing receptor probe was obtained by XbaI/XhoI diges-
tion of a previously described pCDNA3-calcium-sensing
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receptor clone [23]. The GAPDH probe was kindly pro-
vided by Dr. Jose Antonio Urı´a (Oviedo, Spain)
For hybridization, 105 cpm of the transcription product
were diluted in 2 mL of hybridization buffer [50% deion-
ized formamide, 0.5 mol/L sodium phosphate, pH 7.2 [24],
7% sodium dodecyl sulfate (SDS), and 0.25 mol/L NaCl).
Hybridization was carried out over 24 hours at 43◦C with
continuous rotation. The membrane was washed with
2 × standard sodium citrate (SSC)–0.1% SDS at room
temperature for 15 minutes, then in 0.5 × SSC–0.1%
SDS at room temperature for 15 minutes, and finally in
0.1× SSC–0.1% SDS at 65◦C for 15 minutes. Membranes
were exposed to HyperfilmTM MP autoradiographic films
(Amersham Biosciences) for 21 days.
Immunohistochemistry
Calcium-sensing receptor and cellular proliferation
were detected by immunohistochemistry in 5 lm thick se-
rial sections from paraffin-embedded parathyroid glands
using specific antibodies and hematoxylin counterstain-
ing (EnVision+ System) (Dako, Carpinteria, CA,
USA). Calcium-sensing receptor was detected using a
rabbit polyclonal antibody [29] against a 23 amino acid
peptide within the extracellular domain (residues 203
to 226), kindly provided by Dr. Alex Brown and Dr.
Eduardo Slatopolsky (St. Louis, MO, USA). Immuno-
histochemical staining was quantitated as previously de-
scribed [10].
Proliferation was detected using a monoclonal anti-
body to the PCNA (clone PC-10) (Biogenex, San Ramon,
CA, USA) [30]. The number of stained cells was divided
by the total area of the gland, so the results were ex-
pressed as cells/mm2. All the samples were processed at
the same time in order to keep all the possible variables
of the immunostaining procedure constant.
Apoptosis
The detection of apoptosis was carried out by terminal
deoxynucleotidyl transferase (TdT)-mediated deoxyuri-
dine triphosphate (dUTP) nick-end labeling (TUNEL)
(TdT-FragEL) (Oncogene, La Jolla, CA, USA) accord-
ing to manufacturer’s instructions and by propidium io-
dide uptake as previously described [31]. Both techniques
were performed on 5 lm thick sections from paraffin-
embedded parathyroid glands.
Image analysis
All the measurements (calcium-sensing receptor,
PCNA, TUNEL, and propidium iodide uptake) were
performed using an optical microscope (mode; DMR-
XA2) coupled to a digital video camera (model Dc-100)
(Leica Microsystems, Wetzlar, Germany). Captured im-
ages were analyzed using an image analysis system (Leica
Q500IW) and specific software (Leica QWIN standard
version 2.3) (Leica Microsystems).
Statistical analysis
The statistical analysis was performed with the statis-
tical package SPSS 8.0 (SPSS Inc., Chicago, IL, USA)
for Windows. All the comparisons were performed using
nonparametric tests for two independent samples (Mann-
Whitney test) and for two related samples (Wilcoxon
test). Significant differences were considered when P <
0.05.
RESULTS
Effect of aluminum in calcium-sensing
receptor activation
Initial experiments evaluated calcium-sensing receptor
response to calcium in a wide range of concentrations (0.1
to 20 mmol/L). Calcium-sensing receptor activation was
estimated as the percentage of increment in intracellular
calcium ([Ca+2]I) compared to a calcium-free medium.
We found a dose-dependent effect of calcium with maxi-
mum activation at 20 mmol/L calcium (Fig. 1A). Results
were normalized against the [Ca+2]I value corresponding
to a saturating calcium concentration (20 mmol/L cal-
cium). Mean estimated concentration (EC50) was then
calculated and found to be around 3.0 mmol/L (Fig. 1B),
similar to the values we had previously reported [23].
Next, we determined calcium-sensing receptor re-
sponse to aluminum. We assayed four different aluminum
carriers (aluminum serum, aluminum transferrin, alu-
minum citrate, and AlCl3). Unfortunately, some of them
somehow interfered with the fura-2 method. Both, alu-
minum serum and aluminum transferrin showed high flu-
orescence emission at 510 nm, so it was not possible to
differentiate from fura-2 emission. Furthermore, when
aluminum citrate was added to transfected cells, a dra-
matic decrease was observed in fura-2/calcium fluores-
cence emission. The same occurred after the addition of
sodium citrate, but not with NaCl. These findings sug-
gested that citrate was somehow able to enter the cell
and sequestrate intracellular calcium, thus impeding its
binding to fura-2.
Finally, we used AlCl3 in our calcium-sensing receptor
activation assays. Being aware of the risk for aluminum
hydroxide precipitation, soluble aluminum was measured
by graphite-furnace atomic-absorption spectrometry. We
found that additions of 10 lmol/L and 25 lmol/L AlCl3
to the media resulted in soluble aluminum levels of 7.5
and 17.5 lmol/L, respectively. Moreover, despite the wide
range of AlCl3 concentrations used (10, 25, 100, 500, and
1000 lmol/L) it was not possible to increase soluble alu-
minum in the medium beyond 17.5 lmol/L. Although this
fact did not interfere with the measurement of calcium-
sensing receptor activation, it made unable to determine
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Fig. 1. Calcium (Ca) and Aluminum (Al)
activation of the calcium-sensing receptor
(CaR) in human embryonic kidney (HEK-
293) cells transfected with human calcium-
sensing receptor. (A) Addition of CaCl2 from
100 lmol/L to 20 mmol/L. (B) Values nor-
malized against maximum calcium-sensing re-
ceptor activation (20 mmol/L calcium). (C)
Addition of 7.5 or 17.5 lmol/L AlCl3 to a
calcium-free medium. Calcium-sensing recep-
tor activation is expressed in relative units
[percentage of increment in intracellular cal-
cium compared to a medium without cal-
cium or aluminum (Al)]. Values represent the
mean of three independent experiments (er-
ror bars represent STD). Abbreviations are:
RU, relative units; [Ca+2]E, extracellular cal-
cium; [Al+3]E, extracellular aluminum. ∗P <
0.05, when compared to a calcium-free or
aluminum-free medium.
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receptor’s response in a wide range of concentrations.
Consequently, we were unable to calculate maximum
aluminum-induced calcium-sensing receptor activation
and aluminum EC50. However, we found that aluminum
activated the calcium-sensing receptor at a concentration
as low as 7.5 lmol/L, increasing receptor activation by
19%. Moreover, addition of 17.5 lmol/L aluminum ac-
tivated the calcium-sensing receptor by 45% (Fig. 1C).
In both cases results were statistically significant (P <
0.05) compared to a control medium without calcium or
aluminum. The percentage of calcium-sensing receptor
activation with 17.5 lmol/L aluminum was similar to that
obtained by 2 mmol/L extracellular calcium. These re-
sults indicated not only that aluminum was able to acti-
vate the calcium-sensing receptor within the physiologic
range, but also that it was around 100 times more effi-
cient than calcium. Receptor activation by either CaCl2
or AlCl3 was specifically due to calcium and aluminum,
respectively, since no response was detected after the ad-
dition of sodium chloride in a wide range of concentra-
tions (from 10 lmol/L to 1 mmol/L).
Effect of aluminum in PTH synthesis and secretion
There are no stable parathyroid cell lines available and
most studies have shown that dispersed parathyroid cells
in primary cultures lose rapidly their response to calcium
by down-regulation of calcium-sensing receptor expres-
sion [32–35]. Therefore, we decided to use a parathyroid
gland tissue culture model to carry out our experiments.
The model was tested with 10−8 mol/L calcitriol, a well-
known PTH suppressor, before the aluminum experi-
ments were carried out.
There was a important influence of calcium in PTH
inhibition by calcitriol. In a high calcium medium
(1.40 mmol/L calcium), calcitriol only decreased PTH
release by 21.4% (Fig. 2A) and PTH mRNA by 34.8%
[vehicle 1.000 versus calcitriol 0.652 relative units (RU)]
(Fig. 3A). On the contrary, in a low calcium medium
(0.60 mmol/L calcium) the reduction in PTH secretion
and mRNA was considerably higher (80.5% and 59.2%,
respectively) (Figs. 2B and 3A).
Calcium influence was even more evident when using
aluminum carriers. In a high calcium medium, aluminum
serum showed a modest 23.2% inhibition in PTH secre-
tion, whereas aluminum transferrin and aluminum citrate
showed almost no effect (15.9% and 13.2%, respectively)
(Fig. 2A). Northern blot analysis revealed no effect in
PTH mRNA on any of the carriers (data not shown).
However, in a low calcium medium, aluminum serum
inhibited PTH secretion by 50.5% and PTH mRNA by
56.1% (control 1.000 versus aluminum serum 0.439 RU).
Aluminum transferrin and aluminum citrate both inhib-
ited PTH secretion by 66.3% and 50.5%, respectively,
although neither of them were able to decrease PTH
mRNA (Figs. 2B and 3A). PTH inhibition induced by
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Fig. 2. Calcitriol and aluminum (Al) inhibition of parathyroid hor-
mone (PTH) secretion in parathyroid glands cultured with calcitriol
10−8 mol/L (A) or different aluminum carriers (B). (A) 1.40 mmol/L.
(B) 0.60 mmol/L calcium medium. The percentage of PTH released
was compared to a control medium. Values represent the mean of three
independent experiments (error bars represent STD). Abbreviations
are: Al-cit, aluminum citrate 100 lmol/L; Al-tf, aluminum transferrin
100 lmol/L; Al-serum, aluminum-overloaded rat serum 100 lmol/L.
∗P < 0.05, when compared to control. RU is relative units.
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Fig. 3. Analysis of steady-state parathyroid hormone (PTH) RNA. (A) Northern-blot analysis of steady-state PTH mRNA in parathyroid glands
cultured with calcitriol 10−8 mol/L and aluminum serum in a 0.6 mmol/L or 1.40 mmol/L calcium medium (top panel). Densitometric quantification
of PTH mRNA levels normalized against 28S ribosomic RNA (rRNA) and compared to control (bottom panel). A representative experiment for
each of the culture conditions is shown. (B) Quantitative real-time polymerase chain reaction (PCR). PCR analysis of steady-state PTH mRNA
in twenty serum or control glands cultured in a 0.6 mmol/L calcium medium. In this case, PTH mRNA was normalized against 18S rRNA and
compared to control. Values represent the mean of five independent experiments (error bars represent STD). ∗P < 0.01, when compared to control.
RU is relative units.
aluminum serum in a low calcium medium was also as-
sessed by quantitative real-time PCR. We found a 67%
inhibition in PTH mRNA levels (control 1.00 ± 0.00 ver-
sus aluminum serum 0.33 ± 0.18 RU) (P < 0.05), similar
to that observed by Northern blot analysis (Fig. 3B).
Regulation of PTH gene transcription by aluminum
Our data in HEK-293 cells suggested that calcium and
aluminum trigger the same response in parathyroid cells.
Nuclear run-on experiments carried out in rat parathy-
roid glands cultured in a 0.6 mmol/L calcium medium
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Fig. 4. Aluminum (Al) serum posttranscriptional regulation of
parathyroid hormone (PTH) and calcium-sensing receptor (CaR) gene
expression in parathyroid glands cultured in a 0.6 mmol/L calcium
medium. (A) Representative run-on transcription assay experiment.
5 × 107 nuclei were used for each experiment. After the transcription,
105 cpm of the labeled RNA were hybridized with PTH, and calcium-
sensing receptor probes. A glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probe was used as a positive control. A pUC18 DNA frag-
ment was used as a negative control. (B) Quantitative real-time poly-
merase chain reaction (PCR) analysis of cytoplasmic steady-state PTH
and calcium-sensing receptor mRNA isolated from the same parathy-
roid glands used in run-on assays during cell nuclei purification. PTH
and calcium-sensing receptor mRNA levels were normalized against
18S rRNA and compared to control. Values represent the mean of three
independent experiments (error bars represent STD). ∗P < 0.01, when
compared to control. RU is relative units.
showed that aluminum, like calcium, inhibited PTH syn-
thesis by a posttranscriptional mechanism.
Figure 4A shows in vitro transcription products from
control and aluminum serum–cultured glands hybridized
with different cDNA probes. There were no statistical
differences in PTH gene transcription between aluminum
serum and control glands. The same results were observed
in three repeat experiments. On the other hand, quantita-
tive real time PCR analysis of the cytoplasmic mRNA lev-
els from the same glands used in the run-on assays showed
a 77.0% decrease in PTH mRNA in the aluminum serum
glands compared to control (Fig. 4B).
Effect of aluminum on parathyroid cells proliferation
In a previous study using CKD rats we had reported
an additive effect of aluminum and calcium in the inhi-
bition of parathyroid cell proliferation [10]. In this study,
we wanted to determine if aluminum-induced inhibition
of cell proliferation also occurred in parathyroid glands
from normal rats cultured in vitro.
Glands in the aluminum serum group showed a signif-
icantly lower proliferation rate when compared to con-
trol (control 15.8 ± 10.1 versus aluminum serum 2.9 ±
5.1 cells/mm2) (P < 0.01) (Fig. 5). However, it was not
possible to detect any apoptotic event either in the con-
trol or the aluminum-treated glands by TUNEL or pro-
pidium iodide uptake.
Effect of aluminum in calcium-sensing receptor
gene expression
Calcium-sensing receptor mRNA and/or protein levels
can change in a variety of circumstances [32], although lit-
tle is known about the effect of its numerous ligands, in-
cluding calcium or aluminum, in the receptor expression
itself.
We observed a 60.0% decrease in calcium-sensing
receptor mRNA in aluminum serum–cultured glands
compared to control, as measured by quantitative real-
timePCR (control 1.00 ± 0.00 versus aluminum serum
0.40 ± 0.27 RU) (P < 0.05) (Fig. 6A).
When nuclear run-on experiments were carried out,
we found no significant differences in calcium-sensing
receptor gene transcription between aluminum and con-
trol groups (Fig. 4A). However, the analysis of cytoso-
lic mRNA from the same glands used for the run-on
assays revealed a 76.5% decrease in calcium-sensing re-
ceptor mRNA levels in the aluminum group. These re-
sults were similar to those previously observed for PTH
and indicated that aluminum was able to regulate the
calcium-sensing receptor gene by a posttranscriptional
mechanism (Fig. 4B).
Conversely, no differences were observed in calcium-
sensing receptor protein levels detected by immunohisto-
chemistry between aluminum serum and control glands
(control 26.4 ± 9.9 versus aluminum serum 24.4 ± 9.2 RU)
(Fig. 6B and C).
DISCUSSION
Extracellular calcium is the main regulator of parathy-
roid function. Small variations in serum calcium are
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Fig. 5. Analysis of aluminum (Al) serum and
control glands. (A) Photomicrographs of In-
munohistochemical staining of the proliferat-
ing cell nuclear antigen (PCNA) in aluminium
serum and control glands. Hematoxylin
counterstaining (magnification ×100). (B)
Analysis of parathyroid cell proliferation in
aluminum serum and control glands cultured
in a 0.6 mmol/L calcium medium. Data show
the number of PCNA-positive cells assessed
by immunohistochemistry and corrected by
gland surface. Values represent the mean of
three independent experiments with at least
10 glands per group in each experiment (error
bars represent STD). ∗P < 0.01, when com-
pared to control.
sensed by the calcium-sensing receptor leading to large
changes in PTH secretion within seconds or minutes and
in PTH mRNA levels within hours [36, 37]. In a previous
report, we had shown that the inhibitory effect of alu-
minum on PTH secretion also occurred within minutes
[38], thus a rapid and efficient aluminum-sensing mech-
anism may also exist. Moreover, in previous studies we
have observed in vivo aluminum-induced inhibition in
both PTH synthesis and parathyroid cell proliferation [9,
10]. Our findings were similar to those already known
for calcium, thus suggesting that aluminum may regulate
parathyroid function through a calcium-like mechanism.
In this study we have demonstrated that calcium-sensing
receptor plays a key role in aluminum sensing by parathy-
roid cells. Moreover, we have proved that aluminum and
calcium share the same regulatory mechanisms, includ-
ing posttranscriptional regulation of PTH gene and inhi-
bition of parathyroid cell proliferation. Finally, we have
found that aluminum also decreased calcium-sensing re-
ceptor gene expression by a posttranscriptional mecha-
nism. Our findings demonstrated, for the first time, the
regulation of parathyroid calcium-sensing receptor by
aluminum.
Activation of calcium-sensing receptor by AlCl3 has
been already reported by Spurney et al [19], but only
at a supraphysiological concentration. On the contrary,
we [5, 6, 9, 10] and others [1–3, 8] had previously de-
scribed both in vivo and in vitro that aluminum affects
a variety of targets at a micromolar concentration. Tak-
ing all these findings into account, it seemed unlikely that
the calcium-sensing receptor mediated the cellular ac-
tions of aluminum. Nevertheless, great care is demanded
when working with AlCl3 in aqueous solutions at phys-
iologic pH, because aluminum tends to precipitate as
aluminum hydroxide. This was the case in two studies
by Morrissey et al [39] and Morrissey and Slatopolsky
[40]. In the first of these studies they described the in-
hibitory effect of aluminum on PTH secretion at a high
concentration (approximately 2 mmol/L aluminum). In
the second study, it was found that the actual aluminum
levels causing PTH inhibition were not 2 mmol/L alu-
minum but 5 lmol/L, due to formation of nonsoluble
aluminum species. In the present study, we have observed
that the addition of 10 lmol/L and 25 lmol/L AlCl3 to
the media resulted in soluble ionized aluminum levels of
7.5 lmol/L and 17.5 lmol/L, respectively. Moreover, de-
spite the high amounts of AlCl3 added to the media, it
was not possible to increase soluble aluminum concen-
tration above 17.5 lmol/L. As stated before, this fact did
not interfere with the measurements (as it did happen
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Fig. 6. Analysis of steady-state calcium-
sensing receptor mRNA levels. (A) Quan-
titative real-time polymerase chain reaction
(PCR) analysis of steady-state calcium-
sensing receptor mRNA levels in aluminum
(Al) serum and control glands cultured in
a 0.6 mmol/L calcium medium. Calcium-
sensing receptor mRNA levels were normal-
ized against 18S rRNA and compared to
control. (B) Immunohistochemical quantifi-
cation of calcium-sensing receptor protein
corrected by gland surface and expressed
as relative units (RU). Values represent
the mean of three independent experi-
ments with at least 10 glands per group in
each experiment (error bars represent STD).
(C) Photomicrographs of immunohistochem-
ical staining of the calcium-sensing recep-
tor in aluminum serum and control glands.
Hematoxylin counterstaining (magnification
×100).
with aluminum citrate, aluminum transferrin, and alu-
minum serum); however, it made it impossible to study
the effect of high saturating concentrations of aluminum
on calcium-sensing receptor activation. As a result, we
were not able to determine either aluminum-induced
maximum activation or aluminum EC50. We have found
that a concentration as low as 7.5 lmol/L Al activates
the calcium-sensing receptor by 19% and 17.5 lmol/L
aluminum activates the receptor by 45% (in both cases
P < 0.05). This aluminum-induced intracellular calcium
increase is very modest compared to other agonists of the
calcium-sensing receptor [19]. However, the concentra-
tions of calcium necessary to induce a similar degree of
calcium-sensing receptor activation were 0.5 mmol/L and
2 mmol/L, respectively (Fig. 1A). Therefore, aluminum is
able to activate the calcium-sensing receptor at a con-
centration much lower than calcium (100 times) and than
what had been previously described for aluminum (mi-
cromolar instead of millimolar levels) [19], thus raising
the question of whether aluminum and calcium share the
same regulatory mechanisms.
It is widely known that calcium inhibits PTH gene ex-
pression with no effect in gene transcription; however, it
does affect mRNA stability [41]. We had already reported
in normocalcemic CKD rats in vivo that aluminum de-
creased PTH mRNA and protein [9]; however, we did not
know whether aluminum-induced PTH inhibition was a
posttranscriptional mechanism, as in the case of calcium.
In order to perform transcriptional studies and determine
the mechanism by which aluminum regulates parathyroid
function, we set up a rat parathyroid gland culture model
able to reproduce our previous findings in vivo. Since cal-
cium is the main regulator of PTH metabolism and both
hypocalcaemia and hypercalcemia have a dramatic effect
on hormone levels we first tried to optimize culture condi-
tions so that aluminum response was maximal. Almaden
et al [25] have reported that in the rat, PTH secretion
is maximum at 0.6 mmol/L calcium and minimum above
1.25 mmol/L calcium. Therefore, we assayed two different
calcium concentrations. In a high calcium medium, none
of the carriers had any effect on PTH synthesis and only
aluminum serum showed a modest effect in PTH secre-
tion. On the contrary, in a low calcium medium, aluminum
serum showed a 56.1% inhibition in PTH synthesis and
a 50.5% inhibition in hormone secretion. These findings
are similar to those previously reported in vivo [9] where
serum calcium was within the normal range.
The fact that aluminum-induced inhibition of PTH
synthesis occurred only in a low calcium medium was
not unexpected and suggests that calcium and aluminum
may bind to the same sites in the calcium-sensing recep-
tor. Therefore, in a high calcium medium, the calcium-
sensing receptor might have been completely saturated
and there would have been no binding sites available
2494 Gonza´lez-Sua´rez et al: Aluminum and calcium-sensing receptor in PTH regulation
for aluminum. Nevertheless, when a different regulatory
mechanism was involved, as was the case with the ad-
dition of calcitriol, additional inhibition in PTH mRNA
was observed despite the hypercalcemia. On the contrary,
in a low calcium medium, aluminum would have had no
impediment to activate the calcium-sensing receptor and
a decrease PTH mRNA was observed. In this case, the
effect of calcitriol was also higher, as the major regu-
latory mechanism was not active. In accordance to this,
an additive effect in calcium-sensing receptor activation
has been already described for calcium and some other
cations, such as lead or iron at submaximal concentra-
tions [17], although this had never been proved for alu-
minum and additional experiments would be required in
order to prove this fact. Moreover, neither aluminum cit-
rate nor human aluminum transferrin was able to inhibit
PTH mRNA in a low calcium medium, suggesting that a
species-specific carrier such as aluminum serum seems to
be also important.
Regarding transcriptional studies, we carried out three
independent run-on assays. Additionally, cytoplasmic
mature mRNA was isolated from the same parathyroid
glands during cell nuclei purification and analyzed by
quantitative real-time PCR. This allowed us to study
at the same time de novo mRNA synthesis in the nu-
cleus (run-on assays) and posttranscriptional modifi-
cations in the cytoplasm (quantitative real-time PCR
analysis). No differences were observed in run-on assays
between aluminum-cultured and control glands; how-
ever, quantitative real-time PCR analysis of cytoplasmic
PTH mRNA showed a 77.0% decrease in the aluminum
group when compared to control. Taking together, these
results thereby demonstrated a posttranscriptional mech-
anism for aluminum-induced PTH synthesis inhibition
and therefore confirmed a common inhibitory mecha-
nism for calcium and aluminum.
Besides their role in PTH regulation, calcium-sensing
receptor and its biologic ligand calcium exert a suppres-
sive action on parathyroid cell proliferation. The link
between calcium, calcium-sensing receptor, and prolifer-
ation was initially suggested after it was observed that pa-
tients with inactivating mutations in the calcium-sensing
receptor and knockout mice for calcium-sensing receptor
[42] went on to develop parathyroid hyperplasia [43]. In
addition, the type II calcimimetic NPS R-568, a small or-
ganic molecule that potentiates the effects of [Ca+2]E by
acting as a positive allosteric modulator of the calcium-
sensing receptor, inhibited parathyroid cell proliferation
with no effect on apoptosis, both in vivo and in vitro [44–
46]. In this study we found aluminum did not induce de-
tectable parathyroid cell apoptosis, but it did decrease cell
proliferation in the glands by 80%. This finding clearly
demonstrates a direct association between aluminum-
induced activation of the calcium-sensing receptor and
the down-regulation of parathyroid proliferation. Once
again, the effects of exposure to either micromolar alu-
minum or millimolar calcium are identical, thus alu-
minum could be considered a calcimimetic, although the
presence of calcium is not mandatory for it to exert its
actions.
It is well known that the expression of calcium-sensing
receptor mRNA and/or protein can change under certain
circumstances [32]. However, the mechanisms underly-
ing these changes are not fully understood and the reg-
ulation of the calcium-sensing receptor by calcium has
not been formally proven yet [32]. We have detected a
marked decrease in calcium-sensing receptor mRNA lev-
els in the parathyroid glands cultured with aluminum.
The reduction in calcium-sensing receptor expression,
as happened with PTH, was not due to a direct effect
on mRNA synthesis, but the consequence of a posttran-
scriptional mechanism involving mRNA stability. The re-
duction in calcium-sensing receptor mRNA, however,
was not accompanied by a decrease in protein levels, al-
though this does not necessarily signify a lack of effect
on the receptor. Recently Kifor et al [47] suggested a
possible protective mechanism in the parathyroid to pre-
vent the glands from long-term calcium-sensing recep-
tor activation. Prolonged hypercalcemia would provoke
the calpain-mediated cleavage of the calcium-sensing re-
ceptor within the residues 117 to 137 deleting a region
critical for calcium-sensing receptor function. We believe
that 24-hour exposure to aluminum may have the same
effect on the calcium-sensing receptor as did long-term
calcium exposure, so proteolitic inactivation of the recep-
tor would occur. Since we used a polyclonal antibody that
recognizes residues 203 to 226 would have been unable to
detect any calpain-induced deletion in the receptor. How-
ever, further investigation is required in order to prove
our hypothesis.
CONCLUSION
Aluminum activates calcium-sensing receptor in the
micromolar range and inhibits cell proliferation and
PTH gene expression by a posttranscriptional mech-
anism. These results indicate that aluminum impairs
parathyroid function through a mechanism similar to
that elicited by calcium, but with considerably lower
concentrations. Aluminum is also able to down-regulate
calcium-sensing receptor expression by a posttranscrip-
tional mechanism. Functional calcium-sensing receptor
protein could be also decreased by proteolytic cleavage,
although further experiments would be required. Tak-
ing into account that aluminum and calcium seem to
share the same regulatory mechanism, it is likely that
calcium also has an inhibitory effect on calcium-sensing
receptor gene expression. These findings thereby are of
potential clinical interest, since they demonstrate that,
in contrast to previously published studies, aluminum
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activates calcium-sensing receptor at physiologically
achievable concentrations. Thus, aluminum might in-
crease parathyroid sensitivity to calcium, something
already reported with other calcium-sensing receptor ag-
onists [17]. Nevertheless, additional studies are needed in
order to confirm this fact.
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